Chinese tech firm Tencent and British healthcare technology company Medopad are joining forces to develop an artificial intelligence model with the ability to assess motor function in patients with Parkinson’s disease.
Browsing: Motor Control
This article discusses the role of catatonia as part of the symptom cluster of schizophrenia.
New orphan drug designation for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease
A small molecule inhibitor, termed dipraglurant, has been granted orphan drug designation for Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease by the US FDA.
This editorial article discusses a potential contribution of gut defects in the course of amyotrophic lateral sclerosis.
This review is a concise summary of nonmotor symptoms in both genetic and idiopathic Parkinson’s disease patients, highlighting the importance of nonmotor symptoms in research and clinical practice of Parkinson’s disease together with some of the potential differences in pathophysiology and clinical features.